Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.0054 | 1 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0016 | 1 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.0046 | 1 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.00085 | 1 |